Nkarta, Inc. - Common Stock (NKTX)

Nkarta Inc is a biotechnology company focused on the development of novel cell therapies to treat cancer

The company specializes in engineering natural killer (NK) cells, which are a type of immune cell known for their ability to recognize and destroy tumors. Nkarta aims to harness the power of these cells to create innovative, targeted therapies that can enhance the body's immune response against various forms of cancer. Through its research and clinical development efforts, Nkarta seeks to provide meaningful treatment options for patients facing challenging malignancies.